EvoNext Holdings S.A.
OTC: ELVAF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Gerhard Lobmaier
- Employees
- 49
- Headquarters
- Reinach, Switzerland
- IPO year
- 2021
- Market cap
- $15.5M
- Website
- https://evonextholdings.com
Loading ELVAF…
Loading profile data…Frequently asked questions about ELVAF
What does EvoNext Holdings S.A. (ELVAF) do?
EvoNext Holdings SA focuses on the discovery, refinement, and market introduction of innovative components for nutritional, healthcare, and general wellness applications. This enterprise was established in 2004 by Alexandra Santana Sørensen, Søren V. S. Nielsen, and Neil Goldsmith, and maintains its primary base of operations in Reinach, Switzer...
Where does ELVAF trade?
EvoNext Holdings S.A. (ELVAF) trades on the Other OTC.
What sector is ELVAF in?
EvoNext Holdings S.A. (ELVAF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of EvoNext Holdings S.A.?
Gerhard Lobmaier is the chief executive officer of EvoNext Holdings S.A. (ELVAF).
Where is EvoNext Holdings S.A. headquartered?
EvoNext Holdings S.A. is headquartered in Switzerland.
Does ELVAF pay a dividend?
EvoNext Holdings S.A. (ELVAF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ELVAF go public?
EvoNext Holdings S.A. (ELVAF) completed its initial public offering in 2021.